Genflow Biosciences plc (LON:GENF)
London
· Delayed Price · Currency is GBP · Price in GBX 2.000
+0.150 (8.11%)
Feb 21, 2025, 4:19 PM BST
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 6.64 million as of February 21, 2025. Its market cap has increased by 44.23% in one year.
Market Cap
6.64M
Enterprise Value
5.50M
Revenue
598.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 6.64M, a decrease of -80.25%. That is a compound annual growth rate of -40.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 6.64M | 10.14% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 2.06B |
| Oxford Nanopore Technologies | 1.26B |